Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AVPR2 | P30518 | 15/20 | 0.86 |
| ▸ | AVPR1A | P37288 | 15/20 | 0.86 |
| ▸ | OXTR | P30559 | 1/20 | 0.82 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7335432 | 0.92 | AVPR2 (1.00) | AVPR2AVPR1AOXTR | |
| SCHEMBL7341103 | 0.92 | AVPR2 (0.90) | AVPR2AVPR1AOXTR | |
| Lixivaptan SCHEMBL1649340 | 0.90 | AVPR2 (1.00) | AVPR2AVPR1AOXTR | |
| Lixivaptan SCHEMBL29387791 | 0.90 | AVPR2 (1.00) | AVPR2AVPR1AOXTR | |
| Lixivaptan SCHEMBL29373157 | 0.90 | AVPR2 (1.00) | AVPR2AVPR1AOXTR | |
| Lixivaptan SCHEMBL29377065 | 0.90 | AVPR2 (1.00) | AVPR2AVPR1AOXTR | |
| SCHEMBL7338291 | 0.87 | AVPR2 (0.86) | AVPR2AVPR1AOXTR | |
| SCHEMBL8313381 | 0.87 | AVPR2 (1.00) | AVPR2AVPR1AOXTR | |
| SCHEMBL7338085 | 0.86 | AVPR2 (0.84) | AVPR2AVPR1AOXTR | |
| SCHEMBL13590881 | 0.85 | AVPR2 (0.86) | AVPR2AVPR1AOXTR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5624923-A | UROGENITAL AND CARDIOVASCULAR DISORDERS | AMERICAN CYANAMID COMPANY (US) | 1997-04-29 | — | — | US | claimed |
| US-5516774-A | TREATING DISEASES CHARACTERIZED BY EXCESS RENAL REABSORPTION OF WATER | AMERICAN CYANAMID COMPANY (US) | 1996-05-14 | — | — | US | claimed |